These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 25584046)

  • 1. Congenital hyperinsulinism: clinical and molecular characterisation of compound heterozygous ABCC8 mutation responsive to Diazoxide therapy.
    Arya VB; Aziz Q; Nessa A; Tinker A; Hussain K
    Int J Pediatr Endocrinol; 2014; 2014(1):24. PubMed ID: 25584046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Congenital hyperinsulinism due to compound heterozygous mutations in ABCC8 responsive to diazoxide therapy.
    Taylor-Miller T; Houghton J; Munyard P; Kumar Y; Puvirajasinghe C; Giri D
    J Pediatr Endocrinol Metab; 2020 May; 33(5):671-674. PubMed ID: 32267248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and genetic characteristics of patients with congenital hyperinsulinism in 21 non-consanguineous families from Serbia.
    Raicevic M; Milenkovic T; Hussain K; Djordjevic M; Martic J; Todorovic S; Mitrovic K; Sarajlija A; Vukovic R
    Eur J Pediatr; 2021 Sep; 180(9):2815-2821. PubMed ID: 33770274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoallelic ABCC8 mutations are a common cause of diazoxide-unresponsive diffuse form of congenital hyperinsulinism.
    Saint-Martin C; Zhou Q; Martin GM; Vaury C; Leroy G; Arnoux JB; de Lonlay P; Shyng SL; Bellanné-Chantelot C
    Clin Genet; 2015 May; 87(5):448-54. PubMed ID: 24814349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Management and Gene Mutation Analysis of Children with Congenital Hyperinsulinism in South China.
    Xu A; Cheng J; Sheng H; Wen Z; Lin Y; Zhou Z; Zeng C; Shao Y; Li C; Liu L; Li X
    J Clin Res Pediatr Endocrinol; 2019 Nov; 11(4):400-409. PubMed ID: 31208162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and molecular characterisation of 300 patients with congenital hyperinsulinism.
    Kapoor RR; Flanagan SE; Arya VB; Shield JP; Ellard S; Hussain K
    Eur J Endocrinol; 2013 Apr; 168(4):557-64. PubMed ID: 23345197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and histological heterogeneity of congenital hyperinsulinism due to paternally inherited heterozygous ABCC8/KCNJ11 mutations.
    Arya VB; Guemes M; Nessa A; Alam S; Shah P; Gilbert C; Senniappan S; Flanagan SE; Ellard S; Hussain K
    Eur J Endocrinol; 2014 Dec; 171(6):685-95. PubMed ID: 25201519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paternally inherited ABCC8 mutation causing diffuse congenital hyperinsulinism.
    Chandran S; Peng FY; Rajadurai VS; Lu YT; Chang KT; Flanagan SE; Ellard S; Hussain K
    Endocrinol Diabetes Metab Case Rep; 2013; 2013():130041. PubMed ID: 24616771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial diazoxide responsiveness in a neonate with hyperinsulinism due to homozygous ABCC8 mutation.
    Kiff S; Babb C; Guemes M; Dastamani A; Gilbert C; Flanagan SE; Ellard S; Barton J; Dattani M; Shah P
    Endocrinol Diabetes Metab Case Rep; 2019 Feb; 2019():. PubMed ID: 30753133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotype and phenotype correlations in Iranian patients with hyperinsulinaemic hypoglycaemia.
    Senniappan S; Sadeghizadeh A; Flanagan SE; Ellard S; Hashemipour M; Hosseinzadeh M; Salehi M; Hussain K
    BMC Res Notes; 2015 Aug; 8():350. PubMed ID: 26268944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conservatively treated Congenital Hyperinsulinism (CHI) due to K-ATP channel gene mutations: reducing severity over time.
    Salomon-Estebanez M; Flanagan SE; Ellard S; Rigby L; Bowden L; Mohamed Z; Nicholson J; Skae M; Hall C; Craigie R; Padidela R; Murphy N; Randell T; Cosgrove KE; Dunne MJ; Banerjee I
    Orphanet J Rare Dis; 2016 Dec; 11(1):163. PubMed ID: 27908292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Compound Heterozygous Variants of the
    Al Balwi R; Bubshait D; Al Nefily R; Al Ghamdi O
    Children (Basel); 2021 Sep; 8(10):. PubMed ID: 34682101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical presentation and treatment response to diazoxide in two siblings with congenital hyperinsulinism as a result of a novel compound heterozygous ABCC8 missense mutation.
    Galcheva S; Iotova V; Ellard S; Flanagan SE; Halvadzhiyan I; Petrova C; Hussain K
    J Pediatr Endocrinol Metab; 2017 Apr; 30(4):471-474. PubMed ID: 28328534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ABCC8 and KCNJ11 molecular spectrum of 109 patients with diazoxide-unresponsive congenital hyperinsulinism.
    Bellanné-Chantelot C; Saint-Martin C; Ribeiro MJ; Vaury C; Verkarre V; Arnoux JB; Valayannopoulos V; Gobrecht S; Sempoux C; Rahier J; Fournet JC; Jaubert F; Aigrain Y; Nihoul-Fékété C; de Lonlay P
    J Med Genet; 2010 Nov; 47(11):752-9. PubMed ID: 20685672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics and phenotype-genotype analysis in Turkish patients with congenital hyperinsulinism; predominance of recessive KATP channel mutations.
    Demirbilek H; Arya VB; Ozbek MN; Akinci A; Dogan M; Demirel F; Houghton J; Kaba S; Guzel F; Baran RT; Unal S; Tekkes S; Flanagan SE; Ellard S; Hussain K
    Eur J Endocrinol; 2014 Jun; 170(6):885-92. PubMed ID: 24686051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial ABCC8 gene deletion mutations causing diazoxide-unresponsive hyperinsulinaemic hypoglycaemia.
    Flanagan S; Damhuis A; Banerjee I; Rokicki D; Jefferies C; Kapoor R; Hussain K; Ellard S
    Pediatr Diabetes; 2012 May; 13(3):285-9. PubMed ID: 21978130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case report: Exceptional transmission of congenital hyperinsulinism from a focal CHI mother to her diffuse CHI dichorionic diamniotic twins.
    Telehuz D; Plesa O; Bouilloud F; Wucher H; De Lonlay P; Bérat CM; Saint-Martin C; Dupuy O; Arnoux JB
    Front Endocrinol (Lausanne); 2024; 15():1408003. PubMed ID: 38952388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and genetic characterization of congenital hyperinsulinism in Spain.
    Martínez R; Fernández-Ramos C; Vela A; Velayos T; Aguayo A; Urrutia I; Rica I; Castaño L;
    Eur J Endocrinol; 2016 Jun; 174(6):717-26. PubMed ID: 27188453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rare case of congenital hyperinsulinism (CHI) due to dual genetic aetiology involving HNF4A and ABCC8.
    Apperley L; Giri D; Houghton JAL; Flanagan SE; Didi M; Senniappan S
    J Pediatr Endocrinol Metab; 2019 Mar; 32(3):301-304. PubMed ID: 30730840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigating Genetic Mutations in a Large Cohort of Iranian Patients with Congenital Hyperinsulinism.
    Razzaghy-Azar M; Saeedi S; Dayani SB; Enayati S; Abbasi F; Hashemian S; Eshraghi P; Karimdadi S; Tajdini P; Vakili R; Amoli MM; Yaghootkar H
    J Clin Res Pediatr Endocrinol; 2022 Mar; 14(1):87-95. PubMed ID: 34927408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.